Sorafenib in metastatic uveal melanoma: efficacy, toxicity and health-related quality of life in a multicentre phase II studyF. Mouriaux, Florence Joly, A. Thyss et al.|British Journal of Cancer|2016Cited by 48
[Management of adverse effects of targeted therapy toxicities in oncology].Elodie Coquan, Florence Joly, Patrick Henri et al.|PubMed|2012Cited by 3